ARVAST F 10

About ARVAST F 10 is a combination lipid-modifying agent, typically containing Atorvastatin and Fenofibrate. Atorvastatin is an HMG-CoA reductase inhibitor, commonly known as a statin, which primarily works by reducing the liver's production of cholesterol. This leads to a significant reduction in low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol', and also helps to lower triglycerides and slightly increase high-density lipoprotein cholesterol (HDL-C). Fenofibrate, a fibric acid derivative, acts by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha). This activation leads to increased lipolysis and elimination of triglyceride-rich particles from plasma, resulting in substantial reductions in triglycerides and moderate increases in HDL-C. The combination of Atorvastatin and Fenofibrate is particularly effective for patients with mixed dyslipidemia, where both high cholesterol and high triglycerides are present, offering a more comprehensive approach to lipid management than either drug alone. This synergistic action helps to reduce the overall risk of cardiovascular disease by targeting multiple lipid abnormalities. Uses Treatment of mixed dyslipidemia Management of severe hypertriglyceridemia Primary hypercholesterolemia (as an adjunct) Reduction of cardiovascular risk in patients with dyslipidemia Directions For Use Take one tablet once daily, preferably with food, or as directed by your healthcare provider. Swallow the tablet whole. Benefits Effectively lowers LDL-C and triglycerides Significantly increases HDL-C levels Provides comprehensive lipid profile improvement Reduces the risk of pancreatitis in severe hypertriglyceridemia Offers dual action for complex dyslipidemia Contributes to overall cardiovascular health Side Effects Muscle pain or tenderness (myalgia) Headache Nausea Abdominal pain Diarrhea Constipation Elevated liver enzymes Fatigue Dizziness Rash Gallstones (rare) Pancreatitis (rare) Safety Measures Alcohol - Limit alcohol intake as it can increase the risk of liver damage and pancreatitis. Pregnancy - Not recommended during pregnancy due to potential risks to the fetus. Breastfeeding - Avoid during breastfeeding as components may pass into breast milk. Liver - Contraindicated in patients with active liver disease; monitor liver function closely. Kidney - Contraindicated in severe renal impairment; dose adjustment is necessary for moderate impairment. Lung - Generally safe for lung conditions, but rare cases of interstitial lung disease have been reported with statins. Disclaimer MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment. Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub. Our goal is to complement, not replace, the essential doctor-patient relationship.